Cytokinetics announced the FDA approval of aficamten to improve functional capacity and symptoms in adults with symptomatic ...

The FDA approved nerandomilast tablets for adults with progressive pulmonary fibrosis, according to an industry press release ...

Individuals with epilepsy and their caregivers want improved communication and a broader base of information from their ...

HHS has announced proposed regulations that, if finalized, would limit access to gender-affirming care in minors and ...

Leading a nonprofit in eye care, the Armenian EyeCare Project, I hear regularly from colleagues about how much they wish to ...

In this video, Stephen M. Ansell, MD, PhD, discusses findings on the AI-enabled model Lymphovision, which were presented at ASH Annual Meeting and Exposition.

In this video, Stephen M. Ansell, MD, PhD, discusses long-term outcomes from a large prospective cohort study of patients with follicular lymphoma, presented at ASH Annual Meeting and Exposition.

Neuroimmune modulation could be an “emerging therapeutic approach” for patients with rheumatoid arthritis who had incomplete response or intolerance to anti-TNF therapy, according to Minna Kohler, MD, ...

In this video, Henry Chi Hang Fung, MD, FACP, FRCPE, discusses data from part 1a of the phase 3 OLYMPIA-3 study of odronextamab plus chemotherapy in patients with previously untreated diffuse large ...

In this video, Henry Chi Hang Fung, MD, FACP, FRCPE, discusses results from the phase 2 EPCORE-DLBCL-3 trial, presented at the ASH Annual Meeting and Exposition. In stage 2 of the trial, researchers ...

Neuroimmune modulation inhibited progression of structural damage in patients with rheumatoid arthritis who had inadequate response or intolerance to DMARD therapy, according to data presented at ACR ...

In this video, Stephen M. Ansell, MD, PhD, discusses data from ASH Annual Meeting and Exposition on the use of bispecific antibody combinations in follicular lymphoma and mantle cell lymphoma.